article · BMC Public Health
BACKGROUND: Patients with chronic kidney disease (CKD) receiving hemodialysis are at high risk of depression and anxiety, especially in conflict settings where healthcare access is disrupted. No large-scale study in Sudan has simultaneously assessed depression and anxiety during armed conflict. This study aims to estimate the prevalence of anxiety and depressive symptoms and assess their associations with sociodemographic characteristics, dialysis duration, and comorbidities among hemodialysis patients in Sudan during the ongoing armed conflict. METHODS: A multicenter, cross-sectional study was conducted across 13 dialysis units in nine Sudanese states between April and December 2025. A total of 811 adult patients (≥ 18 years) on maintenance hemodialysis were recruited via convenience sampling. Depression and anxiety were assessed using the validated Arabic versions of the PHQ-9 and GAD-7, respectively. Binary logistic regression identified factors associated with depression and anxiety. RESULTS: The prevalence of depressive symptoms was 40.3% (n = 327) and anxiety symptoms 28.6% (n = 232). Comorbid diabetes mellitus (Depression: OR = 2.66, 95% CI: 1.71-4.13; Anxiety: OR = 2.01, 95% CI: 1.28-3.14) and use of neurotoxic medications were associated with higher odds of both conditions. Longer dialysis duration (> 12 months) was associated with lower odds. Female sex and lower dialysis frequency (one session/week) were uniquely linked to higher odds of depression, while older age (≥ 74 years) was protective against anxiety. Geographic variation was observed, with higher odds in Gadarif state. CONCLUSION: Depression and anxiety are highly prevalent among hemodialysis patients in Sudan, exacerbated by ongoing conflict. Diabetes, neurotoxic medications, and regional disparities are key associated factors. Targeted mental health screening and support should be integrated into nephrology care, focusing on high-risk subgroups and conflict-affected regions.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1186/s12889-026-28275-3
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
